‘Neostem – Corporate Marketing & IR’

‘Neostem – Corporate Marketing & IR’

In partnership with AlphaVN securities, we concieved and initiated an investor relations and corporate marketing campaign for emerging stem cell therapy provider Neostem Inc. (Market Cap US$84 million) whose AMR-001 autologous treatment has shown promising results in repairing infarcted myocardium after a severe heart attack (STEMI).

You can see an example of our corporate marketing work for Neostem here.